B4GALNT1 Promotes Hepatocellular Carcinoma Stemness and Progression via Integrin α2β1-Mediated FAK and AKT Activation
Immunohistochemical staining was used to evaluate β-1,4-N-Acetyl-Galactosaminyltransferase 1 (B4GALNT1) expression in hepatocellular carcinoma tissues and adjacent normal liver tissues.
[Cell Metabolism] Using exercise and sarcopenia models, mice lacking IL6Rα on T cells demonstrated deficits in regulatory T cells, their functional maturation, and a more pronounced decline in muscle mass.
[Communications Biology] Based on the up-regulation of catabolism and down-regulation of anabolism, researchers showed genetic mutation-mediated metabolic reprogramming in the progression of cancer cachexia by screening for metabolites and investigating their direct effect on muscle atrophy.
[Acta Pharmacologica Sinica] Researchers investigated the effect of myeloid-derived growth factor to postinjury neointimal formation and the underlying mechanisms. Rat carotid arteries balloon-injured model was established.